SABCS 2022 Conference Coverage
Playback speed
10 seconds
Adjuvant Treatment for HR+/HER2-, Node-Positive, High-Risk eBC: 4-Year Results From the monarchE Study
By
SABCS 2022 Conference Coverage
FEATURING
Wassim Mchayleh
By
SABCS 2022 Conference Coverage
FEATURING
Wassim Mchayleh
288 views
February 7, 2023
Login to view comments.
Click here to Login
Videos